Burns are an important public health problem. [1] In Brazil, it is estimated that they are the cause of approximately 1,000,000 accidents per year. Of these, 100,000 patients will require hospital care, and about 2,500 will die directly or indirectly as a result of their injuries. [2] One of the best ways to treat burn patients is by the use of allografts, which remain the biological dressing of choice and are an important tool. In many cases they can be used for the effective reconstruction of the dermal component. [3] Although allografts are primarily used in the treatment of severe burns, they can also be used for many indications, including extensive skin loss, surgical wounds, lower limb ulcers, pyoderma gangrenosum of diabetic feet and bullous diseases. In addition to serving as a barrier against infection, allografts serve as a temporary biological dressing to help control pain, protect deep structures, promote re-epithelialization and restore the important functions of the skin such as thermal regulation and